Hypertrophic and Keloid Scar Treatment Market Report

Hypertrophic and Keloid Scar Treatment Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Scar Type (Hypertrophic and Keloid), Product Type (Laser Products, Topical Products, Injectables, and Other Products), and End User (Hospitals, Clinics, and Homecare), and Geography

  • Report Code : TIPRE00007237
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 197
Buy Now

[Research Report] The hypertrophic and keloid scar treatment market was valued at US$ 4,498.99 million in 2019 and is projected to reach US$ 9,972.69 million by 2027; it is expected to grow at a CAGR of 10.6% from 2020 to 2027.

A hypertrophic scar refers to a thickened, wide, often raised scar that occurs due to an injury. A hypertrophic scar usually is an effect of an abnormal response to a trauma or injury. Keloids are reddish nodules that are raised in appearance and develop at the site of an injury. Keloids may occur on any part of the body; however, the upper chest, shoulders, and upper back are most prone to keloid formation.

The scope of the hypertrophic and keloid scar treatment market includes scar type, product type, end user, and region. The market for hypertrophic and keloid scar treatment, based on region, is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America. The report offers insights and in-depth analysis of the hypertrophic and keloid scar treatment market emphasizing on various parameters such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players across the world. It also includes COVID–19 impact analysis across all the regions. It is estimated that the market is likely to grow at a slower rate in the following years due to the lockdown situations in various countries that have restricted the supply chain of different non-essential medical products. The pandemic has widely affected the aesthetic industry, which has indirectly prohibited scar treatments.

Lucrative Regions for Hypertrophic and Keloid Scar Treatment Market

Lucrative Regions for Hypertrophic and Keloid Scar Treatment Market

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Market Insights

Advantages of Laser Treatment

Technological advancements have led to the successful use of laser especially 585 nm PDL, Q-switched 532 nm frequency-doubled Nd: YAG, and CO2 lasers, among other types for treating hypertrophic and keloid scars. The laser treatment helps prevent scar formation after surgery; it reduces pain and itching, and allows movement that is otherwise limited by the scar. The treatment is widely employed to treat hypertrophic and keloid scars caused by burns. According to the “Laser Management of Hypertrophic Burn Scars: a Comprehensive Review,” published in January 2020, burn-related injury follows more than 70% of hypertrophic scars. Similarly, according to the World Health Organization (WHO), burn is the major public health problem. Every year, ~265,000 deaths are registered due to scalds, electrical burns, and other burn forms. Moreover, 90% of the burn incidences are reported in low- and middle-income countries.

As excessive collagen deposition leads to the generation of hypertrophic scars that lead to raised scars, laser treatment proves to be effective against them. Moreover, due to being a minimally invasive method, it ensures reduced scar thickness, pain, and postoperative recovery period. It also helps prevent the need for surgical excision and improves skin pigmentation, pliability, height, pruritus, texture, and heat sensitivity, among other skin conditions of the affected areas. This treatment procedure also proves to be cost-effective, especially for those opting for medical tourism. Owing to such advantages, there is high demand for laser treatment curing hypertrophic and keloid scars.

Scar Type-Based Insights

Based on scar type, the hypertrophic and keloid scar treatment market is bifurcated into hypertrophic and keloid. The hypertrophic segment held a larger share of the market in 2019, as hypertrophic scars are more common. Moreover, these scars do not grow outside the borders of the original wound and eventually grow smaller. Additionally, the treatment for hypertrophic scars typically requires non-invasive procedures such as gels, creams, and silicone sheets in the course of minor injuries and laser treatments. Thus, the segment is estimated to register a higher CAGR in the market during the forecast period.

Global Hypertrophic and Keloid Scar Treatment Market, by Scar Type – 2019 & 2027

Global Hypertrophic and Keloid Scar Treatment Market, by Scar Type – 2019 & 2027

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Product Type-Based Insights

Based on product type, the hypertrophic and keloid scar treatment market is segmented into laser products, topical products, injectables, and other products. The injectables segment held the largest share of the market in 2019 and is estimated to register the highest CAGR in the market during the forecast period.

End User-Based Insights

Based on end user, the hypertrophic and keloid scar treatment market is segmented into hospitals, clinics, and homecare. The hospitals segment held the largest share of the market in 2019 and is estimated to register the highest CAGR in the market during the forecast period.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Hypertrophic and Keloid Scar Treatment Market: Strategic Insights

hypertrophic-and-keloid-scar-treatment-market
Market Size Value inUS$ 4,498.99 Million in 2019
Market Size Value byUS$ 9,972.69 Million by 2027
Growth rateCAGR of 10.6% from 2020-2027
Forecast Period2020-2027
Base Year2020
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Inorganic strategies such as partnerships, and mergers and acquisitions are commonly adopted by companies to cater to changing customer demand and maintain their brand name across the world. Market players operating in the hypertrophic and keloid scar treatment market also adopt organic strategies such as product launch and expansion to outstretch their footprint and product portfolio worldwide as well as to meet the growing demand.

By Scar Type

  • Hypertrophic
  • Keloid

By Product Type

  • Laser Products
    • CO2
    • Pulse-Dyed
    • Other Laser Products
  • Topical Products
    • Creams
    • Gels
    • Silicone Sheets
    • Other Topical Products
  • Injectables
  • Other Products

By End User

  • Hospitals
  • Clinics
  • Homecare

By

Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of APAC
  • Middle East & Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of MEA
  • South and Central America (SCAM)
    • Brazil
    • Argentina
    • Rest of SCAM

Company Profiles

  • Alliance Pharma plc
  • Mölnlycke HEALTH CARE AB.
  • Smith & Nephew
  • Newmedical Technology Inc.
  • Rejûvaskin
  • Sonoma Pharmaceuticals, Inc.
  • Suneva Medical
  • HRA Pharma
  • Lumenis
  • Perrigo Company plc.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Scar Type , Product Type , and End User , and Geography

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

Frequently Asked Questions


What are Hypertrophic and Keloid Scars ?

A hypertrophic scar refers to a thickened, wide, often raised scar that occurs due to an injury. A hypertrophic scar usually is an effect of an abnormal response to a trauma or injury. Keloids are reddish nodules that are raised in appearance and develop at the site of an injury. Keloids may occur on any part of the body; however, the upper chest, shoulders, and upper back are most prone to keloid formation.

What are the driving factors for the hypertrophic and keloid scar treatment market across the globe?

The growth of the market is attributed to advantages of laser treatment and increasing incidences of injuries. However, unavailability of universal treatment due to high costs, side effects, and scanty awareness hinder the market growth.

What is the cost of hypertrophic and keloid scar treatment?

The costs of the treatments of these scars are much higher, and they may cost US$ 1,000–5,000, or more, per treatment. The cost may also differ from product to product and treatment cycles.

The List of Companies - Hypertrophic and Keloid Scar Treatment Market

  1. Alliance Pharma plc
  2. Mölnlycke HEALTH CARE AB.
  3. Smith & Nephew
  4. Newmedical Technology Inc.
  5. Rejûvaskin
  6. Sonoma Pharmaceuticals, Inc.
  7. Suneva Medical
  8. HRA Pharma
  9. Lumenis
  10. Perrigo Company plc

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Hypertrophic and Keloid Scar Treatment Market